These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers. Guix M, Granja Nde M, Meszoely I, Adkins TB, Wieman BM, Frierson KE, Sanchez V, Sanders ME, Grau AM, Mayer IA, Pestano G, Shyr Y, Muthuswamy S, Calvo B, Krontiras H, Krop IE, Kelley MC, Arteaga CL. J Clin Oncol; 2008 Feb 20; 26(6):897-906. PubMed ID: 18180460 [Abstract] [Full Text] [Related]
24. Dissecting the role of cell signaling versus CD8+ T cell modulation in propranolol antitumor activity. Li W, Wan J, Chen C, Zhou C, Liao P, Hu Q, Hu J, Wang Y, Zhang Y, Peng C, Huang Y, Huang W, Zhang W, Mcleod HL, He Y. J Mol Med (Berl); 2022 Sep 20; 100(9):1299-1306. PubMed ID: 35895125 [Abstract] [Full Text] [Related]
30. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways. Rivas MA, Carnevale RP, Proietti CJ, Rosemblit C, Beguelin W, Salatino M, Charreau EH, Frahm I, Sapia S, Brouckaert P, Elizalde PV, Schillaci R. Exp Cell Res; 2008 Feb 01; 314(3):509-29. PubMed ID: 18061162 [Abstract] [Full Text] [Related]
31. Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-kappaB signaling in HER2-overexpressing breast cancer cells. Seo HS, Choi HS, Choi HS, Choi YK, Um JY, Choi I, Shin YC, Ko SG. Anticancer Res; 2011 Oct 01; 31(10):3301-13. PubMed ID: 21965740 [Abstract] [Full Text] [Related]
35. A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer. Gargiulo L, May M, Rivero EM, Copsel S, Lamb C, Lydon J, Davio C, Lanari C, Lüthy IA, Bruzzone A. J Mammary Gland Biol Neoplasia; 2017 Mar 01; 22(1):43-57. PubMed ID: 28074314 [Abstract] [Full Text] [Related]
36. β‑blockers inhibit the viability of breast cancer cells by regulating the ERK/COX‑2 signaling pathway and the drug response is affected by ADRB2 single‑nucleotide polymorphisms. Xie WY, He RH, Zhang J, He YJ, Wan Z, Zhou CF, Tang YJ, Li Z, Mcleod HL, Liu J. Oncol Rep; 2019 Jan 01; 41(1):341-350. PubMed ID: 30542705 [Abstract] [Full Text] [Related]
38. NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells. Laag E, Majidi M, Cekanova M, Masi T, Takahashi T, Schuller HM. Int J Cancer; 2006 Oct 01; 119(7):1547-52. PubMed ID: 16671086 [Abstract] [Full Text] [Related]